What is Icecure Medical (ICCM) stock price today?

Icecure Medical (ICCM) currently trades at $0.27 per share. The stock has a market capitalization of $23.07M and a P/E ratio of —x.

Is ICCM stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Icecure Medical has a Smart Value Score of 30/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is -14.19.

What is Icecure Medical's revenue and earnings?

Icecure Medical has trailing twelve-month (TTM) revenue of $3.38M with profit margins of 0.00%. Earnings per share (EPS) is $-0.24.

Is Icecure Medical financially healthy?

Icecure Medical's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of -14.19 places it in the distress.

ICCM

Icecure Medical

NASDAQ: ICCM · HEALTHCARE · MEDICAL DEVICES

$0.27

-1.28% today

Updated 2026-04-29

Market cap

$23.07M

P/E ratio

—

P/S ratio

6.83x

EPS (TTM)

$-0.24

Dividend yield

—

52W range

$0 – $1

Volume

0.6M

Market cap

$23.07M

P/E ratio

—

P/S ratio

6.83x

EPS (TTM)

$-0.24

Dividend yield

—

52W range

$0 – $1

Volume

0.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

6.0

Growth

6.0

Quality

2.5

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-14.2

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$2.73

+908.89%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 46.20% QoQ

+ Debt/equity 0.03x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -14.19 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-5.47M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$3.08M	$3.23M	$3.29M	$3.38M	$3.38M
Net income	$-17.22M	$-14.65M	$-15.32M	$-15.06M	$-4.25M
EPS	—	—	—	—	$-0.24
Free cash flow	$-15.18M	$-13.00M	$-12.63M	$-14.61M	$-5.47M
Profit margin	-558.09%	-453.76%	-465.45%	-445.61%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ICCM	$23.07M	30	6.0	2.5	5.0	6.0	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Icecure Medical trades at $0.27. Our Smart Value Score of 30/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -14.19, it sits in the distress. TTM revenue stands at $3.38M.

Frequently asked questions

What is Icecure Medical's stock price?

Icecure Medical (ICCM) trades at $0.27.

Is Icecure Medical overvalued?

Smart Value Score 30/100 (Grade F, Strong Sell).

What is the price target of Icecure Medical (ICCM)?

The analyst target price is $2.73, representing +908.9% upside from the current price of $0.27.

What is Icecure Medical's revenue?

TTM revenue is $3.38M.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

-14.19 — distress.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.icecure-medical.com

Quick metrics

P/S ratio6.83x

ROE-188.80%

Beta2.52

50D MA$0.49

200D MA$0.74

Shares out0.08B

Float0.04B

Short ratio—

Avg volume0.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ICCM vs LLY →ICCM vs JNJ →ICCM vs ABBV →Stock screener →